SEPTIN5
Basic information
Region (hg38): 22:19714503-19724224
Previous symbols: [ "PNUTL1", "SEPT5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SEPTIN5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 18 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 18 | 8 | 1 |
Variants in SEPTIN5
This is a list of pathogenic ClinVar variants found in the SEPTIN5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-19714616-A-C | not specified | Uncertain significance (Aug 02, 2023) | ||
22-19714623-C-T | not specified | Uncertain significance (May 31, 2022) | ||
22-19714624-G-A | Benign (Sep 12, 2018) | |||
22-19719689-A-G | not specified | Uncertain significance (Oct 20, 2024) | ||
22-19719838-C-A | not specified | Uncertain significance (Oct 03, 2022) | ||
22-19719867-G-T | not specified | Uncertain significance (Aug 02, 2023) | ||
22-19719871-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
22-19719872-G-A | not specified | Uncertain significance (Dec 06, 2024) | ||
22-19719874-A-C | not specified | Uncertain significance (Jan 22, 2024) | ||
22-19720124-G-A | not specified | Likely benign (May 26, 2023) | ||
22-19720141-C-G | not specified | Uncertain significance (Dec 02, 2021) | ||
22-19720192-A-G | not specified | Uncertain significance (Dec 27, 2023) | ||
22-19720202-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
22-19720336-G-A | not specified | Uncertain significance (Jul 27, 2024) | ||
22-19720346-A-C | not specified | Uncertain significance (Sep 16, 2021) | ||
22-19720369-C-T | not specified | Uncertain significance (Oct 26, 2024) | ||
22-19720388-A-T | not specified | Uncertain significance (Sep 10, 2024) | ||
22-19720439-C-G | not specified | Uncertain significance (Jan 03, 2024) | ||
22-19720446-C-G | not specified | Uncertain significance (Jan 10, 2022) | ||
22-19720550-C-T | Likely benign (Jul 16, 2018) | |||
22-19720553-C-T | not specified | Uncertain significance (Mar 28, 2023) | ||
22-19720675-G-A | Likely benign (Apr 03, 2018) | |||
22-19720772-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
22-19720845-C-T | Likely benign (May 21, 2018) | |||
22-19720858-C-T | not specified | Uncertain significance (Jan 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SEPTIN5 | protein_coding | protein_coding | ENST00000455784 | 12 | 10309 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.927 | 0.0733 | 125521 | 0 | 7 | 125528 | 0.0000279 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.63 | 128 | 243 | 0.526 | 0.0000157 | 2459 |
Missense in Polyphen | 58 | 120.16 | 0.48268 | 1137 | ||
Synonymous | -0.749 | 111 | 101 | 1.09 | 0.00000727 | 664 |
Loss of Function | 3.70 | 3 | 21.6 | 0.139 | 0.00000106 | 245 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000266 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Filament-forming cytoskeletal GTPase (By similarity). May play a role in cytokinesis (Potential). May play a role in platelet secretion (By similarity). {ECO:0000250, ECO:0000305}.;
- Pathway
- Parkinson,s disease - Homo sapiens (human);Parkin-Ubiquitin Proteasomal System pathway;Parkinsons Disease Pathway
(Consensus)
Recessive Scores
- pRec
- 0.278
Intolerance Scores
- loftool
- 0.413
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.07
Haploinsufficiency Scores
- pHI
- 0.284
- hipred
- Y
- hipred_score
- 0.882
- ghis
- 0.630
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.998
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sept5
- Phenotype
- homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype;
Gene ontology
- Biological process
- synaptic vesicle targeting;regulation of exocytosis;cytoskeleton-dependent cytokinesis;regulation of synaptic vesicle exocytosis
- Cellular component
- plasma membrane;septin ring;synaptic vesicle;microtubule cytoskeleton;septin complex
- Molecular function
- GTPase activity;structural molecule activity;protein binding;GTP binding;protein-containing complex scaffold activity